Herskowitz Neil's most recent trade in Journey Medical Corp was a trade of 20,000 Common Stock, $0.0001 par value done . Disclosure was reported to the exchange on Aug. 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Journey Medical Corp | Neil Herskowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2025 | 20,000 | 108,618 | - | 0 | Common Stock, $0.0001 par value | |
| Journey Medical Corp | Neil Herskowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2025 | 7,173 | 88,618 | - | 0 | Common Stock, $0.0001 par value | |
| Checkpoint Therapeutics Inc | Neil Herskowitz | Director | 28 May 2025 | 147,007 | 0 (0%) | 0% | - | COMMON STOCK | ||
| Checkpoint Therapeutics Inc | Neil Herskowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 12,195 | 147,007 (0%) | 0% | 0 | COMMON STOCK | |
| Checkpoint Therapeutics Inc | Neil Herskowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2024 | 17,638 | 134,812 (0%) | 0% | 0 | COMMON STOCK | |
| Avenue Therapeutics Inc | Herskowitz Neil | Director | Sale of securities on an exchange or to another person at price $ 2.00 per share. | 02 Dec 2024 | 23 | 97 (0%) | 0% | 2 | 46 | COMMON STOCK, PAR VALUE $0.0001 |
| Avenue Therapeutics Inc | Neil Herskowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2024 | 30,000 | 30,000 | - | - | Employee stock option (right to buy) | |
| Journey Medical Corp | Neil Herskowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2024 | 9,728 | 81,445 | - | 0 | Common Stock, $0.0001 par value | |
| Checkpoint Therapeutics Inc | Neil Herskowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2024 | 50,000 | 117,174 (0%) | 0% | 0 | COMMON STOCK | |
| Checkpoint Therapeutics Inc | Neil Herskowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2024 | 32,051 | 67,174 (0%) | 0% | 0 | COMMON STOCK | |
| Journey Medical Corp | Neil Herskowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 27,472 | 71,717 | - | 0 | Common Stock, par value $0.0001 per share | |
| Mustang Bio Inc | Neil Herskowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2023 | 7,246 | 19,703 (0%) | 0% | 0 | COMMON STOCK, PAR VALUE $0.0001 | |
| Avenue Therapeutics Inc | Neil Herskowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 100,000 | 100,000 | - | - | Employee stock option (right to buy) | |
| Checkpoint Therapeutics Inc | Neil Herskowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 17,483 | 35,123 (0%) | 0% | 0 | COMMON STOCK | |
| Mustang Bio Inc | Neil Herskowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2022 | 71,664 | 186,861 (0%) | 0% | 0 | COMMON STOCK, PAR VALUE $0.0001 | |
| Journey Medical Corp | Neil Herskowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2022 | 14,245 | 44,245 | - | 0 | Common Stock, par value $0.0001 per share | |
| Journey Medical Corp | Neil Herskowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 30,000 | 30,000 | - | 0 | COMMON STOCK | |
| Mustang Bio Inc | Neil Herskowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2021 | 13,774 | 115,197 (0%) | 0% | 0 | COMMON STOCK | |
| Avenue Therapeutics Inc | Neil Herskowitz | Director | Purchase of securities on an exchange or from another person at price $ 3.99 per share. | 06 May 2021 | 2,500 | 134,724 (0%) | 0% | 4.0 | 9,975 | Common Stock |